The Florida International Medical Expo (FIME) is the largest medical device development and trade professional in the Americas, and the current FIME returns to beautiful Miami. The 29th International Medical Equipment Exhibition was grandly opened on June 26th at the Miami Beach Convention Center in Florida, USA. The three-day FIME exhibition attracted more than 1,200 exhibitors from 105 countries. As the leading medical exhibition in North America, FIME's on-site feedback was enthusiastic, and ENMIND brought all the products to the FIME exhibition.

On-site colleagues patiently explain products to customers

As a professional provider of intravenous infusion products and minimally invasive surgical consumables, ENMIND brought the V5 series products to FIME this year.

The newly launched V5 series products are dedicated to providing customers with a more professional and better customer experience. The weight of the whole machine is only 1.5 kilograms. The compact and convenient, transport-free design allows doctors to efficiently complete treatments whenever and wherever. The V5 series' 4.3-inch color full touch screen combined with efficient UI interface interaction design greatly reduces the threshold for doctors to get started, making it easier for users to focus on data observation. V5 series products not only give users a simple and efficient experience in ease of use, but also the precision performance far exceeds the user's expectations. DPS dynamic pressure monitoring system, digital real-time display pressure value and alarm limit setting, the plugging status is clear at a glance, the nurse can promptly notice that the blockage has occurred and is processed quickly. The perfect occlusion management setting can further reduce patient blood pressure fluctuations.

Infusion Pump EN-V5 

The customers of the on-site experience have shown great interest in the products. They also agreed that ENMIND will break through more on the road of precision treatment and lead the future. Through this FIME exhibition, ENMIND will continue to explore the entire American market, contributing to the development of the industry and better serving doctors and patients.